Liver scan may predict deadly failure after big operations
NCT ID NCT02753517
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special liver scan (hepatobiliary scintigraphy) can predict liver failure in 326 patients undergoing major liver surgery. The scan measures how well the remaining liver works, which may be more useful than just measuring its size. If accurate, it could help doctors identify high-risk patients and improve surgical planning.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hepatobiliary scintigraphy (imaging scan)
What this could lead to
If successful, this scan could help surgeons better predict which patients are at risk of liver failure after major liver surgery, potentially reducing complications.
What could go wrong
This is an observational study, not a treatment trial. The scan's accuracy may be limited, and results may not apply to all patients or hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HPHôpital Beaujon,
Paris, France
-
CHRU, Hôpital Claude Huriez
Lille, France
-
CHU
Bordeaux, France
-
CHU
Grenoble, France
-
CHU
Marseille, France
-
CHU
Rouen, France
-
CHU
Toulouse, France
-
Centre Leon Berard - Lyon 08
Lyon, 69008, France
-
Chru Nancy - Hopitaux de Brabois
Nancy, France
-
Hopital Croix-Rousse - Hcl - Lyon 04
Lyon, 69008, France
-
Hopital Estaing - Chu63 - Clermont Ferrand
Clermont-Ferrand, France
-
Hôpital Nord, CHU
Amiens, France